TNFAIP3 expression was significantly downregulated (p < 0.001, Wilcoxon test) in breast invasive carcinoma (BRCA) and 11 other cancer types, including lung adenocarcinoma (LUAD), colon adenocarcinoma (COAD), and bladder urothelial carcinoma (BLCA). Here, TNFAIP3 is linked to cancer.